From: <Saved by Microsoft Internet Explorer 5>
Subject: 25 August 2005
Date: Fri, 26 Aug 2005 17:57:43 +0300
MIME-Version: 1.0
Content-Type: text/html;
	charset="iso-8859-1"
Content-Transfer-Encoding: quoted-printable
Content-Location: file://C:\Documents%20and%20Settings\Administrator\My%20Documents\ravensclaw\bepast\2005-08-25%20Aug%20Newsletter%20Oseltamivir%20is%20Necessary%20but%20not%20sufficient[1].htm
X-MimeOLE: Produced By Microsoft MimeOLE V6.00.2800.1506

<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.0 Transitional//EN">
<HTML xmlns=3D"http://www.w3.org/TR/REC-html40" xmlns:v =3D=20
"urn:schemas-microsoft-com:vml" xmlns:o =3D=20
"urn:schemas-microsoft-com:office:office" xmlns:w =3D=20
"urn:schemas-microsoft-com:office:word"><HEAD><TITLE>25 August =
2005</TITLE>
<META http-equiv=3DContent-Type content=3D"text/html; =
charset=3Dwindows-1252">
<META content=3DWord.Document name=3DProgId>
<META content=3D"MSHTML 6.00.2800.1505" name=3DGENERATOR>
<META content=3D"Microsoft Word 9" name=3DOriginator><LINK=20
href=3D"./2005-08-25%20Aug%20Newsletter%20Oseltamivir%20is%20Necessary%20=
but%20not%20sufficient%5B1%5D_files/filelist.xml"=20
rel=3DFile-List><!--[if gte mso 9]><xml>
 <o:DocumentProperties>
  <o:Author>Daniel R.Lucey </o:Author>
  <o:LastAuthor>Valued Sony Customer</o:LastAuthor>
  <o:Revision>2</o:Revision>
  <o:TotalTime>3</o:TotalTime>
  <o:Created>2005-08-26T14:56:00Z</o:Created>
  <o:LastSaved>2005-08-26T14:56:00Z</o:LastSaved>
  <o:Pages>2</o:Pages>
  <o:Words>666</o:Words>
  <o:Characters>3801</o:Characters>
  <o:Company>Consulting</o:Company>
  <o:Lines>31</o:Lines>
  <o:Paragraphs>7</o:Paragraphs>
  <o:CharactersWithSpaces>4667</o:CharactersWithSpaces>
  <o:Version>9.3821</o:Version>
 </o:DocumentProperties>
</xml><![endif]--><!--[if gte mso 9]><xml>
 <w:WordDocument>
  <w:PunctuationKerning/>
 </w:WordDocument>
</xml><![endif]-->
<STYLE>@page Section1 {size: 8.5in 11.0in; margin: 1.0in 1.25in 1.0in =
1.25in; mso-header-margin: .5in; mso-footer-margin: .5in; =
mso-paper-source: 0; }
P.MsoNormal {
	FONT-SIZE: 12pt; MARGIN: 0in 0in 0pt; FONT-FAMILY: "Times New Roman"; =
mso-style-parent: ""; mso-pagination: widow-orphan; =
mso-fareast-font-family: "Times New Roman"
}
LI.MsoNormal {
	FONT-SIZE: 12pt; MARGIN: 0in 0in 0pt; FONT-FAMILY: "Times New Roman"; =
mso-style-parent: ""; mso-pagination: widow-orphan; =
mso-fareast-font-family: "Times New Roman"
}
DIV.MsoNormal {
	FONT-SIZE: 12pt; MARGIN: 0in 0in 0pt; FONT-FAMILY: "Times New Roman"; =
mso-style-parent: ""; mso-pagination: widow-orphan; =
mso-fareast-font-family: "Times New Roman"
}
A:link {
	COLOR: blue; TEXT-DECORATION: underline; text-underline: single
}
SPAN.MsoHyperlink {
	COLOR: blue; TEXT-DECORATION: underline; text-underline: single
}
A:visited {
	COLOR: purple; TEXT-DECORATION: underline; text-underline: single
}
SPAN.MsoHyperlinkFollowed {
	COLOR: purple; TEXT-DECORATION: underline; text-underline: single
}
DIV.Section1 {
	page: Section1
}
</STYLE>
<!--[if gte mso 9]><xml>
 <o:shapedefaults v:ext=3D"edit" spidmax=3D"2050"/>
</xml><![endif]--><!--[if gte mso 9]><xml>
 <o:shapelayout v:ext=3D"edit">
  <o:idmap v:ext=3D"edit" data=3D"1"/>
 </o:shapelayout></xml><![endif]--></HEAD>
<BODY lang=3DEN-US style=3D"tab-interval: .5in" vLink=3Dpurple =
link=3Dblue>
<DIV class=3DSection1>
<P class=3DMsoNormal><SPAN=20
style=3D"FONT-SIZE: 9pt; FONT-FAMILY: Arial; mso-bidi-font-size: 12.0pt; =
mso-bidi-font-family: 'Times New Roman'">25=20
August 2005<o:p></o:p></SPAN></P>
<P class=3DMsoNormal><SPAN=20
style=3D"FONT-SIZE: 9pt; FONT-FAMILY: Arial; mso-bidi-font-size: 12.0pt; =
mso-bidi-font-family: 'Times New Roman'"><![if =
!supportEmptyParas]><![endif]>&nbsp;<o:p></o:p></SPAN></P>
<P class=3DMsoNormal><B style=3D"mso-bidi-font-weight: normal"><SPAN=20
style=3D"FONT-SIZE: 9pt; FONT-FAMILY: Arial; mso-bidi-font-size: 12.0pt; =
mso-bidi-font-family: 'Times New Roman'">=93Necessary=20
but Not Sufficient=94: The 3 Million Courses of Oseltamivir for H5N1 =
Nascent=20
Pandemic Control.<SPAN style=3D"mso-spacerun: yes">&nbsp;&nbsp; =
</SPAN>Five (5)=20
Other Criteria are Required, Similar to the US Cities Readiness =
Initiative=20
(CRI). <o:p></o:p></SPAN></B></P>
<P class=3DMsoNormal><B style=3D"mso-bidi-font-weight: normal"><SPAN=20
style=3D"FONT-SIZE: 9pt; FONT-FAMILY: Arial; mso-bidi-font-size: 12.0pt; =
mso-bidi-font-family: 'Times New Roman'"><![if =
!supportEmptyParas]><![endif]>&nbsp;<o:p></o:p></SPAN></B></P>
<P class=3DMsoNormal><SPAN=20
style=3D"FONT-SIZE: 9pt; FONT-FAMILY: Arial; mso-bidi-font-size: 12.0pt; =
mso-bidi-font-family: 'Times New Roman'">In=20
the recent publication by Neil<SPAN style=3D"mso-spacerun: yes">&nbsp;=20
</SPAN>Ferguson (from Imperial College London) and colleagues in =
<U>Nature</U>=20
titled =93Strategies for containing an emerging influenza pandemic in =
Southeast=20
Asia=94 six (6) criteria were listed that had to be achieved to predict =
a high=20
probability of<SPAN style=3D"mso-spacerun: yes">&nbsp; =
</SPAN>controlling pandemic=20
influenza when it first began to occur.<SPAN style=3D"mso-spacerun: =
yes">&nbsp;=20
</SPAN>Importantly, only one of these six criteria included having a =
rapidly=20
deployable stockpile of at least 3 million courses of the anti-H5N1 oral =
drug=20
oseltamivir (=93Tamiflu=94). <o:p></o:p></SPAN></P>
<P class=3DMsoNormal><SPAN=20
style=3D"FONT-SIZE: 9pt; FONT-FAMILY: Arial; mso-bidi-font-size: 12.0pt; =
mso-bidi-font-family: 'Times New Roman'"><![if =
!supportEmptyParas]><![endif]>&nbsp;<o:p></o:p></SPAN></P>
<P class=3DMsoNormal><SPAN=20
style=3D"FONT-SIZE: 9pt; FONT-FAMILY: Arial; mso-bidi-font-size: 12.0pt; =
mso-bidi-font-family: 'Times New Roman'">Thus,=20
the news announced 24 August that the WHO had received a commitment from =
Roche=20
to donate 3 million treatment courses of oseltamivir for use as a =
stockpile=20
against pandemic flu should be seen as necessary but not sufficient =
because the=20
other five (5) criteria for success must also be =
met.<o:p></o:p></SPAN></P>
<P class=3DMsoNormal><SPAN=20
style=3D"FONT-SIZE: 9pt; FONT-FAMILY: Arial; mso-bidi-font-size: 12.0pt; =
mso-bidi-font-family: 'Times New Roman'"><![if =
!supportEmptyParas]><![endif]>&nbsp;<o:p></o:p></SPAN></P>
<P class=3DMsoNormal><SPAN=20
style=3D"FONT-SIZE: 9pt; FONT-FAMILY: Arial; mso-bidi-font-size: 12.0pt; =
mso-bidi-font-family: 'Times New Roman'">The=20
complete six (6) criteria quoted from the conclusion of the =
<U>Nature</U> paper=20
are:<o:p></o:p></SPAN></P>
<P class=3DMsoNormal><SPAN=20
style=3D"FONT-SIZE: 9pt; FONT-FAMILY: Arial; mso-bidi-font-size: 12.0pt; =
mso-bidi-font-family: 'Times New Roman'">1).=20
=93Rapid identification of the original case =
clusters=94<o:p></o:p></SPAN></P>
<P class=3DMsoNormal><SPAN=20
style=3D"FONT-SIZE: 9pt; FONT-FAMILY: Arial; mso-bidi-font-size: 12.0pt; =
mso-bidi-font-family: 'Times New Roman'">2).=20
=93Rapid, sensitive case detection and delivery of treatment to targeted =
groups,=20
preferably within 48 hours of a case arising=94<o:p></o:p></SPAN></P>
<P class=3DMsoNormal><SPAN=20
style=3D"FONT-SIZE: 9pt; FONT-FAMILY: Arial; mso-bidi-font-size: 12.0pt; =
mso-bidi-font-family: 'Times New Roman'">3).=20
Effective delivery of treatment to a high proportion of the targeted =
population,=20
preferably &gt; 90%.<o:p></o:p></SPAN></P>
<P class=3DMsoNormal><SPAN=20
style=3D"FONT-SIZE: 9pt; FONT-FAMILY: Arial; mso-bidi-font-size: 12.0pt; =
mso-bidi-font-family: 'Times New Roman'">4).=20
Sufficient stockpiles of drug, preferably 3 million or more courses of=20
oseltamivir<o:p></o:p></SPAN></P>
<P class=3DMsoNormal><SPAN=20
style=3D"FONT-SIZE: 9pt; FONT-FAMILY: Arial; mso-bidi-font-size: 12.0pt; =
mso-bidi-font-family: 'Times New Roman'">5).=20
Population cooperation with the containment strategy and, in particular, =
any=20
social distancing measures introduced<o:p></o:p></SPAN></P>
<P class=3DMsoNormal><SPAN=20
style=3D"FONT-SIZE: 9pt; FONT-FAMILY: Arial; mso-bidi-font-size: 12.0pt; =
mso-bidi-font-family: 'Times New Roman'">6).=20
International cooperation in policy development, epidemic surveillance =
and=20
control strategy implementation.<SPAN style=3D"mso-spacerun: yes">&nbsp; =

</SPAN>Containment is unlikely if Ro (the average number of secondary =
cases for=20
each primary case of a contagious disease) exceeds 1.8 for the new =
pandemic=20
strain.=94<SPAN style=3D"mso-spacerun: yes">&nbsp; =
</SPAN><o:p></o:p></SPAN></P>
<P class=3DMsoNormal><SPAN=20
style=3D"FONT-SIZE: 9pt; FONT-FAMILY: Arial; mso-bidi-font-size: 12.0pt; =
mso-bidi-font-family: 'Times New Roman'"><![if =
!supportEmptyParas]><![endif]>&nbsp;<o:p></o:p></SPAN></P>
<P class=3DMsoNormal><SPAN=20
style=3D"FONT-SIZE: 9pt; FONT-FAMILY: Arial; mso-bidi-font-size: 12.0pt; =
mso-bidi-font-family: 'Times New Roman'">Understandably,=20
the Ro will not be known at the time it is essential to implement a =
containment=20
policy at the start of the pandemic. In addition, it should be =
emphasized that=20
this model focuses on a <U>rural</U> outbreak initiating the pandemic, =
and=20
recognition of such an outbreak while it is still rural. Specifically, =
the=20
authors state in their section on =93Effect of antiviral prophylaxis=94 =
that<SPAN=20
style=3D"mso-spacerun: yes">&nbsp; </SPAN>the =91maximum number of<SPAN=20
style=3D"mso-spacerun: yes">&nbsp; </SPAN>oseltamivir courses that would =
be needed=20
to control the pandemic in which cases arise in Bangkok at an early =
stage of the=20
outbreak can increase by an =93unfeasible order of=20
magnitude=94.<o:p></o:p></SPAN></P>
<P class=3DMsoNormal><SPAN=20
style=3D"FONT-SIZE: 9pt; FONT-FAMILY: Arial; mso-bidi-font-size: 12.0pt; =
mso-bidi-font-family: 'Times New Roman'"><![if =
!supportEmptyParas]><![endif]>&nbsp;<o:p></o:p></SPAN></P>
<P class=3DMsoNormal><SPAN=20
style=3D"FONT-SIZE: 9pt; FONT-FAMILY: Arial; mso-bidi-font-size: 12.0pt; =
mso-bidi-font-family: 'Times New Roman'">The=20
other five criteria<SPAN style=3D"mso-spacerun: yes">&nbsp; </SPAN>above =
deserve=20
even more effort and resources now that the criteria of having 3 million =
courses=20
of oseltamivir is being met<SPAN style=3D"mso-spacerun: yes">&nbsp; =
</SPAN>(10=20
capsules/course for either one standard treatment course at two =
capsules/day,=20
or<SPAN style=3D"mso-spacerun: yes">&nbsp; </SPAN>for a single 10 day =
prophylactic=20
course (as per Ferguson et al. in their modeling paper in <U>Nature</U>) =
at one=20
capsule/day).<o:p></o:p></SPAN></P>
<P class=3DMsoNormal><SPAN=20
style=3D"FONT-SIZE: 9pt; FONT-FAMILY: Arial; mso-bidi-font-size: 12.0pt; =
mso-bidi-font-family: 'Times New Roman'"><![if =
!supportEmptyParas]><![endif]>&nbsp;<o:p></o:p></SPAN></P>
<P class=3DMsoNormal><SPAN=20
style=3D"FONT-SIZE: 9pt; FONT-FAMILY: Arial; mso-bidi-font-size: 12.0pt; =
mso-bidi-font-family: 'Times New Roman'">In=20
fact, similarities can be recognized between the six most critical =
criteria=20
outlined above in this model to control a nascent influenza pandemic in =
rural=20
Asia and the US Cities Readiness Initiative (CRI) (described on the CDC =
website=20
at<SPAN style=3D"mso-spacerun: yes">&nbsp; </SPAN><A=20
href=3D"http://www.bt.cdc.gov/cri/qa.asp">www.bt.cdc.gov/cri/qa.asp</A>) =
Both=20
require (1) rapid detection of<SPAN style=3D"mso-spacerun: yes">&nbsp; =
</SPAN>the=20
disease, (2) rapid delivery of treatment or prophylaxis preferably =
within 48=20
hours, (3) effective delivery to a high proportion of the targeted =
population,=20
preferably &gt; 90%, (4) sufficient stockpiles of the needed =
antimicrobial drugs=20
e.g., from the Strategic National Stockpile (SNS) in the case of the =
CRI), (5)=20
cooperation of the involved population with any Public Health =
containment=20
policies, and (6) both national and international cooperation in =
epidemic=20
surveillance and policy<SPAN style=3D"mso-spacerun: yes">&nbsp;=20
</SPAN>development.<SPAN style=3D"mso-spacerun: yes">&nbsp;=20
</SPAN><o:p></o:p></SPAN></P>
<P class=3DMsoNormal><SPAN=20
style=3D"FONT-SIZE: 9pt; FONT-FAMILY: Arial; mso-bidi-font-size: 12.0pt; =
mso-bidi-font-family: 'Times New Roman'"><![if =
!supportEmptyParas]><![endif]>&nbsp;<o:p></o:p></SPAN></P>
<P class=3DMsoNormal><SPAN=20
style=3D"FONT-SIZE: 9pt; FONT-FAMILY: Arial; mso-bidi-font-size: 12.0pt; =
mso-bidi-font-family: 'Times New Roman'">CRI=20
efforts in the USA that began in ~21 cities and metropolitan areas over =
the past=20
year to implement distribution of antibiotics within 48 hours e.g., =
after an=20
aerosol attack with anthrax, have proven how difficult meeting this 48 =
hour=20
criteria would be in one or more US cities. To be able to meet such a 48 =
hour=20
criteria for delivering oseltamivir to a large number of persons in =
rural Asia=20
is probably no less challenging and would require much multidisciplinary =

international preparedness planning. <o:p></o:p></SPAN></P>
<P class=3DMsoNormal><SPAN=20
style=3D"FONT-SIZE: 9pt; FONT-FAMILY: Arial; mso-bidi-font-size: 12.0pt; =
mso-bidi-font-family: 'Times New Roman'"><![if =
!supportEmptyParas]><![endif]>&nbsp;<o:p></o:p></SPAN></P>
<P class=3DMsoNormal><SPAN=20
style=3D"FONT-SIZE: 9pt; FONT-FAMILY: Arial; mso-bidi-font-size: 12.0pt; =
mso-bidi-font-family: 'Times New Roman'"><![if =
!supportEmptyParas]><![endif]>&nbsp;<o:p></o:p></SPAN></P>
<P class=3DMsoNormal><SPAN=20
style=3D"FONT-SIZE: 9pt; FONT-FAMILY: Arial; mso-bidi-font-size: 12.0pt; =
mso-bidi-font-family: 'Times New Roman'"><![if =
!supportEmptyParas]><![endif]>&nbsp;<o:p></o:p></SPAN></P>
<P class=3DMsoNormal><SPAN=20
style=3D"FONT-SIZE: 9pt; FONT-FAMILY: Arial; mso-bidi-font-size: 12.0pt; =
mso-bidi-font-family: 'Times New Roman'">Daniel=20
R.Lucey, MD, MPH<o:p></o:p></SPAN></P>
<P class=3DMsoNormal><SPAN=20
style=3D"FONT-SIZE: 9pt; FONT-FAMILY: Arial; mso-bidi-font-size: 12.0pt; =
mso-bidi-font-family: 'Times New Roman'">Adjunct=20
Professor of Microbiology and Immunology<o:p></o:p></SPAN></P>
<P class=3DMsoNormal><SPAN=20
style=3D"FONT-SIZE: 9pt; FONT-FAMILY: Arial; mso-bidi-font-size: 12.0pt; =
mso-bidi-font-family: 'Times New Roman'">Georgetown=20
University School of Medicine<o:p></o:p></SPAN></P>
<P class=3DMsoNormal><SPAN=20
style=3D"FONT-SIZE: 9pt; FONT-FAMILY: Arial; mso-bidi-font-size: 12.0pt; =
mso-bidi-font-family: 'Times New Roman'">Director,=20
Center for Biologic Counterterrorism and Emerging =
Diseases<o:p></o:p></SPAN></P>
<P class=3DMsoNormal><SPAN=20
style=3D"FONT-SIZE: 9pt; FONT-FAMILY: Arial; mso-bidi-font-size: 12.0pt; =
mso-bidi-font-family: 'Times New Roman'">Department=20
of Emergency Medicine, Washington Hospital Center<o:p></o:p></SPAN></P>
<P class=3DMsoNormal><SPAN=20
style=3D"FONT-SIZE: 9pt; FONT-FAMILY: Arial; mso-bidi-font-size: 12.0pt; =
mso-bidi-font-family: 'Times New Roman'">Washington=20
DC<o:p></o:p></SPAN></P>
<P class=3DMsoNormal><SPAN=20
style=3D"FONT-SIZE: 9pt; FONT-FAMILY: Arial; mso-bidi-font-size: 12.0pt; =
mso-bidi-font-family: 'Times New Roman'">e-mail:=20
<A=20
href=3D"mailto:Daniel.R.Lucey@Medstar.net">Daniel.R.Lucey@Medstar.net</A>=
<o:p></o:p></SPAN></P>
<P class=3DMsoNormal><SPAN=20
style=3D"FONT-SIZE: 9pt; FONT-FAMILY: Arial; mso-bidi-font-size: 12.0pt; =
mso-bidi-font-family: 'Times New Roman'">website:=20
<A=20
href=3D"http://www.bepast.org/">http://www.bepast.org/</A><o:p></o:p></SP=
AN></P>
<P class=3DMsoNormal><SPAN=20
style=3D"FONT-SIZE: 9pt; FONT-FAMILY: Arial; mso-bidi-font-size: 12.0pt; =
mso-bidi-font-family: 'Times New Roman'"><![if =
!supportEmptyParas]><![endif]>&nbsp;<o:p></o:p></SPAN></P>
<P class=3DMsoNormal><SPAN=20
style=3D"FONT-SIZE: 9pt; FONT-FAMILY: Arial; mso-bidi-font-size: 12.0pt; =
mso-bidi-font-family: 'Times New Roman'"><![if =
!supportEmptyParas]><![endif]>&nbsp;<o:p></o:p></SPAN></P>
<P class=3DMsoNormal><SPAN=20
style=3D"FONT-SIZE: 9pt; FONT-FAMILY: Arial; mso-bidi-font-size: 12.0pt; =
mso-bidi-font-family: 'Times New Roman'"><![if =
!supportEmptyParas]><![endif]>&nbsp;<o:p></o:p></SPAN></P>
<P class=3DMsoNormal><SPAN=20
style=3D"FONT-SIZE: 9pt; FONT-FAMILY: Arial; mso-bidi-font-size: 12.0pt; =
mso-bidi-font-family: 'Times New Roman'"><SPAN=20
style=3D"mso-spacerun: yes">&nbsp;</SPAN><o:p></o:p></SPAN></P>
<P class=3DMsoNormal><SPAN=20
style=3D"FONT-SIZE: 9pt; FONT-FAMILY: Arial; mso-bidi-font-size: 12.0pt; =
mso-bidi-font-family: 'Times New Roman'"><![if =
!supportEmptyParas]><![endif]>&nbsp;<o:p></o:p></SPAN></P>
<P class=3DMsoNormal><SPAN=20
style=3D"FONT-SIZE: 9pt; FONT-FAMILY: Arial; mso-bidi-font-size: 12.0pt; =
mso-bidi-font-family: 'Times New Roman'"><![if =
!supportEmptyParas]><![endif]>&nbsp;<o:p></o:p></SPAN></P></DIV></BODY></=
HTML>
